Previous findings have shown that downregulation of FANCD2 expression by siRNA-mediated approach in U87 and T98MG cells can increase cellular sensitivity to glioma chemotherapeutic agents, TMZ and BCNU, demonstrating that FA repair pathway is involved in glioma resistance to DNA alkylating agents [43]. The gene discussed is FANCD2; the disease is central nervous system cancer.